Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bausch Health Companies Inc (NY: BHC ) 9.500 -0.190 (-1.96%) Official Closing Price Updated: 7:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bausch Health Companies Inc < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday November 01, 2024 Via Benzinga Bausch Health Announces Third Quarter 2024 Results October 30, 2024 Via ACCESSWIRE ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence October 27, 2024 Via ACCESSWIRE Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt October 26, 2024 IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders. Via Benzinga Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags October 21, 2024 S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. Via Benzinga Topics Bankruptcy Stocks Exposures Financial Legal US Equities Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners August 13, 2024 Via ACCESSWIRE Bausch Health Announces Second Quarter 2024 Results July 30, 2024 Via ACCESSWIRE Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings July 29, 2024 The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. Via Benzinga Topics Economy Exposures Interest Rates Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces October 14, 2024 Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb. Via Benzinga Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 October 09, 2024 Via ACCESSWIRE Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises October 08, 2024 Via ACCESSWIRE Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value September 25, 2024 The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden. Via MarketBeat Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? September 22, 2024 Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. Via Benzinga Topics Economy Exposures Interest Rates Bausch Health Responds to Market Rumors July 24, 2024 Via ACCESSWIRE Bausch Health Welcomes Two New Members to the Executive Leadership Team July 19, 2024 Via ACCESSWIRE Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues September 16, 2024 Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off. Via Benzinga Topics Supply Chain Exposures Supply Chain Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? September 16, 2024 Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns. Via Investor's Business Daily Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens September 04, 2024 Bank of Canada cuts key policy rate by 25 basis points to 4.25% and suggests further cuts if inflation continues to ease. Via Benzinga Topics Economy Exposures Interest Rates Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock August 02, 2024 Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper Sandler downgrades BHC to Underweight with a price target of $3, citing... Via Benzinga BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy July 24, 2024 Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism. Via InvestorPlace Topics Bankruptcy Exposures Financial Legal US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? August 01, 2024 Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market... Via Benzinga Why Bausch health Shares Are Falling Today July 24, 2024 Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged... Via Benzinga Topics Bankruptcy Exposures Financial Legal Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November August 01, 2024 After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a... Via Benzinga Stocks Plummet After Tech Earnings, Manufacturing Data July 24, 2024 The Dow Jones Industrial Average is down triple digits, while the S&P 500 Index eyes its worst daily percentage drop since September 2023. Via Talk Markets Topics Stocks Exposures US Equities Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 July 11, 2024 Via ACCESSWIRE Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 24, 2024 Via Benzinga Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals June 20, 2024 Via ACCESSWIRE Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences June 14, 2024 Via ACCESSWIRE Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults May 23, 2024 Via ACCESSWIRE Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 May 17, 2024 Via ACCESSWIRE < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
